Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling

Research output: Contribution to journalReviewpeer-review

  1. Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae

    Research output: Contribution to journalJournal articlepeer-review

  2. Editorial: Interactions of Pentraxins and Complement in Infection, Inflammation, and Cancer

    Research output: Contribution to journalEditorialpeer-review

  3. Improved induced innate immune response after cART initiation in people with HIV

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

Background: Knowledge of the genetic variation underlying Primary Immune Deficiency (PID) is increasing. Reanalysis of genome-wide sequencing data from undiagnosed patients with suspected PID may improve the diagnostic rate.

Methods: We included patients monitored at the Department of Infectious Diseases or the Child and Adolescent Department, Rigshospitalet, Denmark, for a suspected PID, who had been analysed previously using a targeted PID gene panel (457 PID-related genes) on whole exome- (WES) or whole genome sequencing (WGS) data. A literature review was performed to extend the PID gene panel used for reanalysis of single nucleotide variation (SNV) and small indels. Structural variant (SV) calling was added on WGS data.

Results: Genetic data from 94 patients (86 adults) including 36 WES and 58 WGS was reanalysed a median of 23 months after the initial analysis. The extended gene panel included 208 additional PID-related genes. Genetic reanalysis led to a small increase in the proportion of patients with new suspicious PID related variants of uncertain significance (VUS). The proportion of patients with a causal genetic diagnosis was constant. In total, five patients (5%, including three WES and two WGS) had a new suspicious PID VUS identified due to reanalysis. Among these, two patients had a variant added due to the expansion of the PID gene panel, and three patients had a variant reclassified to a VUS in a gene included in the initial PID gene panel. The total proportion of patients with PID related VUS, likely pathogenic, and pathogenic variants increased from 43 (46%) to 47 (50%), as one patient had a VUS detected in both initial- and reanalysis. In addition, we detected new suspicious SNVs and SVs of uncertain significance in PID candidate genes with unknown inheritance and/or as heterozygous variants in genes with autosomal recessive inheritance in 8 patients.

Conclusion: These data indicate a possible diagnostic gain of reassessing WES/WGS data from patients with suspected PID. Reasons for the possible gain included improved knowledge of genotype-phenotype correlation, expanding the gene panel, and adding SV analyses. Future studies of genotype-phenotype correlations may provide additional knowledge on the impact of the new suspicious VUSs.

Original languageEnglish
Article number906328
JournalFrontiers in Immunology
Volume13
Pages (from-to)906328
ISSN1664-3224
DOIs
Publication statusPublished - 2022

Bibliographical note

Copyright © 2022 Mørup, Nazaryan-Petersen, Gabrielaite, Reekie, Marquart, Hartling, Marvig, Katzenstein, Masmas, Lundgren, Murray, Helleberg and Borgwardt.

    Research areas

  • Exome, Genetic Association Studies, Humans, Primary Immunodeficiency Diseases/diagnosis, Whole Exome Sequencing, Whole Genome Sequencing, small INDELs, gene panel analysis, whole exome sequencing, whole genome sequencing (WGS), primary immune deficiencies (PID), reanalysis approach, single nucleotide variant analysis, structural variation analysis

ID: 79705400